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that 30-60% of diabetic patients have associated 
hypertension.[8] 
Recently it has been hypothesized that oxidative stress 
is a key player in the pathogenesis of hypertension.[9,10] 
Endothelial cells play a major role in arterial relaxation. 
Nitric oxide is released by the endothelium and causes 
vascular relaxation.[11] Nitric oxide is rapidly degraded 
by the oxygen-derived free radical superoxide anion. 
Superoxide anion acts as a vasoconstrictor and is a 
major determinant of nitric oxide (NO) biosynthesis 
and bioavailability. It, therefore, can modify the 
endothelial function. Human hypertension is associated 
in a decrease in NO bioavailability and an increase in 
oxidative stress.[12] Decreased catalase and/or superoxide 
dismutase and reduced levels of reactive oxygen species 
(ROS) or reactive nitrogen species (RNS) scavengers such 
as glutathione, and vitamins C and E also contribute to 
oxidative stress.[13,14] Activation of reduction–oxidation 
(redox)-dependent signaling cascades and NADPH 
oxidase-driven generation of ROS are involved in 
the role of angiotensin-II-induced hypertension.[15] 
Angiotensin II stimulates nonphagocytic NADPH 
INTRODUCTION
Hypertension (HTN) is a chronic medical condition that 
is rarely accompanied by any symptoms. It is usually 
identified through screening or when the patient is 
seeking for an unrelated problem. Hypertension is a 
major risk factor for myocardial infarction, heart failure, 
stroke, peripheral arterial disease, aortic aneurysm, and 
is a cause of chronic kidney disease.[1-4] Elevation of 
arterial blood pressure is associated with a shortened 
life expectancy.[1,5,6] 
In 2000, nearly one billion people of the adult world 
population had hypertension. The rate of blood 
pressure is increasing, so that in 1995, 43 million people 
(22%) in the United States suffered hypertension or 
were taking antihypertensive medication,[7] in 2006, 
76 million US adults (34% of the population) had 
hypertension.
Hypertension is often associated with metabolic 
abnormalities such as diabetes and dyslipidemia and 
the rate of these diseases is increasing too. It is estimated 
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oxidase, causing the accumulation of hydrogen peroxide, 
superoxide, and peroxynitrite.[16]
In obesity and diabetes that are usually associated with 
hypertension, chronic oxidative stress is present.[17-20] In 
this regard, caloric restriction in fasting and obese subjects 
leads to a marked reduction in ROS generation and other 
indices of oxidative stress.[17]
A reduction in superoxide dismutase and glutathione 
peroxidase activity have been observed in newly 
diagnosed and untreated hypertensive subjects, which 
are inversely correlated with blood pressure. Hydrogen 
peroxide production is also higher in hypertensive 
subjects.[21] Furthermore, hypertensive patients have 
higher lipid hydroperoxide production. Oxidative stress 
is also markedly increased in hypertensive patients with 
renovascular disease.[22]
Furthermore, there is a correlation between renin activation 
and elevated oxidative stress which may suggest that 
angiotensin II is a stimulus for oxidant stress in renovascular 
disease.[23] The role of oxidative stress in hypertension and 
the possible mechanisms involved are well documented in a 
couple of recently published original and review papers[9,10] 
and are further discussed in this paper. If oxidative stress is 
indeed a cause of hypertension, then, these all suggest that 
antioxidants should have beneficial effect on hypertension 
control. Hence, reduction of oxidative damage may result 
in a reduction in blood pressure. This matter is the main 
focus of this paper. Other than further discussing about 
oxidative stress and its importance in hypertension, a list of 
medicinal plants which have been reported to be effective 
in hypertension is also presented.
Oxidative stress and its importance in hypertension
Oxidative stress (OS) is believed to be involved in many 
types of disease processes. Oxidative stress occurs when 
there is an imbalance between the generation of ROS 
and the antioxidant defense systems [Figure 1]. The ROS 
comprises many molecules with different effects on the 
cellular function. ROS and RNS are regularly formed as 
the result of excess oxidative stress or even normal organ 
functions. In any biological system there should be an 
important balance between the formation of ROS and 
RNS, and their removal.[11] The reactive species including 
superoxide (O2
-), hydroxyl radical (HO•), hydrogen 
peroxide (H2O2), peroxynitrite (ONOO
-), nitrogen oxide 
(NO•), and hypochlorous acid (HOCl) are produced in 
normal metabolic pathways and scavenged by antioxidants, 
however, in excess amounts, they can exert harmful 
reactions. In the vascular system, superoxide and hydrogen 
peroxide are particularly important. Superoxide, one of 
the most important sources of initiating radicals in the 
body, is produced in mitochondria and leaks outside of the 
mitochondria. To maintain an oxido/redox balance, organs 
protect themselves from the toxicity of excess ROS/RNS 
in different ways, including the use of endogenous and 
exogenous antioxidants [Figure 1].[12] 
As was mentioned earlier, there is a strong association 
between blood pressure and some oxidative stress-related 
parameters. Genetic deficiencies in ROS-generating 
enzymes have also been shown to be lower in blood 
pressure compared with their wild-type counterparts.[24] 
Furthermore, in isolated arteries from hypertensive humans 
and animals, antioxidant bioactivity is reduced, redox-
dependent signaling is amplified and ROS production 
is enhanced.[25] The beneficial effects of antihypertensive 
agents, such as angiotensin I converting enzyme inhibitors, 
angiotensin-II receptor antagonists, b-adrenergic, and 
calcium channel blockers might be mediated, at least in 
part, by decreasing vascular oxidative stress.[26-30]
Different sources of ROS might exist in blood vessels. One 
of the best characterized sources of ROS is NADPH oxidase. 
Several other enzymes including NO synthase, xanthine 
oxidase, and mitochondrial enzymes may also contribute 
to ROS generation. The vasculature and kidney are the rich 
sources of NADPH oxidase-derived ROS, having important 
role in vascular damage and renal dysfunction under.[31] 
This system functions as an electron donor and catalyses 
the reduction of oxygen by NADPH which increases the 
generation of superoxide upregulation of NADPH oxidase 
in hypertensive patients.[31] 
The function of NADPH oxidase-derived superoxide is 
inactivation of NO in the reaction that forms peroxynitrite, 
leading to impaired endothelium dependent vasodilation. 
The activation of NADPH oxidase has been strongly 
associated with hypertension.[32] Oxidation or deficiency 
of tetrahydrobiopterin (BH4) and L-arginine which are two 
cofactors for endothelium-derived NO synthase (eNOS) 
action are associated with the uncoupling of the L-arginine-
NO pathway that results in increased eNOS-mediated 
generation of superoxide and decreased formation of NO. 
NADPH oxidase is the initial source of ROS. Superoxide 
combines with NO, which is synthesized by eNOS, to 
form peroxynitrite. In turn, peroxynitrite oxidizes and Figure 1: The balance between oxidative stress and antioxidant defence system
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destabilizes eNOS to produce additional superoxide.[33] 
BH4 is highly sensitive to oxidation and upper oxide leads 
to BH4 oxidation, which promotes eNOS uncoupling and 
further ROS production. Xanthine oxidase that is believed 
to be involved in hypertension is another important source 
of ROS in the vascular endothelium. It catalyzes the last 
two steps of purine metabolism and reduction of oxygen 
to superoxide.[32] Hypertensive rats have demonstrated 
increased ROS production and elevated levels of endothelial 
xanthine oxidase, which is associated with increased 
arteriolar tone.[31] Xanthine oxidase may also have a function 
in end-organ injury in hypertensive patients.[34]
The endothelium is also greatly involved in ROS production 
and furthermore releases agents that regulate vasomotor 
function. Under some pathophysiological circumstances, 
endothelium-derived vasoconstricting factors, such as 
angiotensin-1 and -II, vasoconstrictor prostaglandins and 
thromboxane A2, urotensin II, and superoxide anions, can 
be released and contribute to the paradoxical vasoconstrictor 
effects.[34]
As was described, NO has an important role in vascular 
tone. The decrease in bioavailability of NO in the vasculature 
reduces hypertension by increasing in vasodilation capacity. 
The NO is synthesized by NOS from oxygen and arginine. 
NO, in addition to its antiproliferative and vasorelaxing 
roles, has an important role in antagonizing the effects of 
endothelins, AT-II, and ROS.[35]
Reduced NO levels can be attributed to elevated levels of 
ROS. Superoxide combines with NO to form peroxynitrite 
that oxidizes BH4 and destabilizes eNOS to produce more 
superoxide and enhancing the development of oxidative 
stress.[33]
Angiotensin-II also, as a potent activator of NADPH oxidase, 
contributes to the production of ROS. Angiotensin-II 
not only increases NADPH oxidase activity but also 
upregulates the activity of superoxide dismutase, possibly 
to compensate the increased levels of ROS.[36]
Captopril and enalapril prevented increases in blood 
pressure in young, spontaneously hypertensive rats by 
inhibiting ACE. The ability of angiotensin-II to induce 
endothelial dysfunction is also due to its ability to 
downregulate soluble guanylyl cyclase, thereby leading to 
impaired NO/cGMP signaling. The decrease in NO will also 
lead to reduced acetylcholine-mediated vasodilation, and 
an overall increase in ROS is associated in the reduction in 
the bioavailability of NO.[37]
Urotensin-II which is the most potent identified 
vasoconstrictor also acts through the activation of NADPH 
oxidase.[31] In addition, overexpression of inducible NOS 
increases blood pressure via central activation of the 
sympathetic nervous system, which is mediated by an 
increase in oxidative stress.[38]
In general, although there are multiple sources producing 
ROS, the most potential sources of excessive ROS in 
hypertension are as follows: NADPH oxidase, eNOS, 
mitochondria, xanthine oxidase, cytochrome P450 
epoxygenase, cycloxygenase 1 and 2, transition metals (e.g. 
Iron).[38-40]
Effects of antioxidants on hypertension
Antioxidants are compounds that are able to trap ROS 
and thus may be capable of reducing oxidative damage 
and possibly blood pressure.[26-33] Antioxidants terminate 
the chain reactions of ROS by removing free radical 
intermediates, and inhibit other oxidation reactions. They 
do this by being oxidized themselves, so antioxidants are 
often reducing agents such as ascorbic acid, vitamin E or 
polyphenols that act by different mechanisms [Table 1].[41-43]
As was mentioned earlier, there might be a correlation 
between stress oxidative and arterial hypertension[9,10] 
This matter has led to the use of exogenous antioxidants to 
reduce blood pressure.[44]
Polyphenols that are widespread antioxidants in vegetables 
and fruits in some studies have demonstrated their 
beneficial role in prevention and therapy of hypertension. 
Polyphenols inhibit ROS-producing enzymes such as 
NADPH and xanthine oxidases, activate, and enhance eNOS 
expression and increase glutathione. These have improved 
endothelial function, subsequent normalization of vascular 
tone, and an overall antihypertensive effect.[45] 
The antioxidants vitamins C and E and other antioxidants 
have been considered as possible therapy for decreasing 
Table 1: Exogenous antioxidants and their mechanisms 
in hypertension[34]
Antioxidant Mechanisms
Vitamin C eNOS upregulation, NADPH oxidase downregulation, 
Protection against BH4 oxidation, ROS scavenging
Vitamin E eNOS upregulation, NADPH oxidase downregulation, 
Regulation of mitochondrial ROS synthesis, ROS 
scavenging
N-acetylcysteine Protection against BH4 oxidation, ROS scavenging
Polyphenols Production of NO, ROS scavenging, Iron chelation, 
Enzyme modulation
Allopurinol Inhibition of xanthine oxidase
Selenium Cofactor of glutathione peroxidase, thioredoxin 
reductases and selenoprotein P, Inhibition of 
nuclear factor kappa-B activation
eNOS = Endothelial nitric oxide synthase; NADPH = Nicotinamide adenine 
dineucleotide phosphate; ROS = Reactive oxygen species; BH4 = Tetrahydrobiopterin; 
NO = Nitric oxide
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oxidative stress and thereby lowering blood pressure. 
Additionally vitamins C and E down-regulate NADPH 
oxidase, a major source of ROS in the vascular wall, and 
up-regulate eNOS, both of these effects lower blood 
pressure.[46] In this regard, a randomized double-blind 
clinical trial other than demonstrating a specific association 
between oxidative-stress-related parameters and blood 
pressure, documented enhancement of antioxidant status 
by supplementation with antioxidants vitamins C and E 
and their hypotensive properties.[47] 
Combination supplement with vitamin C, vitamin E, beta-
carotene, and zinc also resulted in a significant reduction 
in systolic blood pressure and a nonsignificant reduction 
in diastolic blood pressure.]48] 
The diets rich in fruits and vegetables reduce blood 
pressure in hypertensive and normotensive patients.[49] 
The modification in diet results in an increase in serum 
antioxidant capacity and a decrease in malondialdehyde, 
an in-vitro marker of lipid peroxidation, suggestive of a 
reduction in oxidative stress.[49-53] In a study, increase of fruit 
and vegetable intake for a period of 6 months to the diet of 
hypertensive subjects, increased blood antioxidant capacity 
and decreased in systolic and diastolic blood pressure.[49] 
Large clinical trials examining the effects of antioxidants 
specifically on blood pressure are rare. Moreover, 
the majority of large clinical trials did not find any 
antihypertensive effects of antioxidants.[53] A large study 
reported no improvement in blood pressure after treatment 
with a combination of vitamin C, vitamin E, and beta 
carotene versus placebo after 5 years in subjects thought to 
be at high risk of cardiovascular disease.[54] Furthermore, a 
meta-analysis has revealed no clear benefit after antioxidant 
supplementation in cardiovascular mortality.[55]
In general, long-term clinical trials have failed to consistently 
support the antihypertensive effects of antioxidants. 
Results of studies showing that supplemental antioxidants 
intake lowers blood pressure in short-term trials are 
inconsistent. Most of such studies have looked at all-cause or 
cardiovascular mortality, rarely focusing on blood pressure 
as a primary end point.[49,50,56] 
Possible reasons for these disappointing outcomes might 
also be relate to 1) the trial design, 2) the type of antioxidants 
used, and 3) Patient cohorts included in trials. With respect 
to antioxidants, it is possible that dosing regimens and 
duration of therapy were insufficient or agents examined 
were ineffective and nonspecific. It is also possible that 
the antioxidants administered are inaccessible to the 
source of free radicals, particularly if ROS are generated in 
intracellular organelles and compartments.[9]
Furthermore, antioxidants do not inhibit ROS production 
and antioxidant vitamins do not scavenge H2O2, which 
may be more important than •O2− in cardiovascular 
diseases.[9] 
Regarding cohorts included in large trials, most subjects had 
significant cardiovascular disease, in which case damaging 
effects of oxidative stress might be irreversible. Moreover, 
not all hypertensions are related to oxidative stress and there 
are not any large clinical trials in which patients be recruited 
based on evidence of elevated ROS formation. Also, none 
of the large clinical trials were designed to examine effects 
of antioxidants specifically on blood pressure.
However, most therapeutic guidelines suggest that 
the general population consumes a diet emphasizing 
antioxidant-rich fruits and vegetables and whole grains.[46]
From the literature review we may conclude that the diets 
high in antioxidants (fruits and vegetables) are capable of 
reducing blood pressure and cardiovascular diseases, but 
this is not the case for diet supplementations.[56-59]
The possible explanation is that, in the diet, there is a mix 
of antioxidants and it is well recognized that they work as 
a continuous chain, while supplementation is usually given 
using one or two substances. Therefore, the antioxidant 
chain is not completely available. 
Moreover, it is well known that after scavenging free 
radicals, if an antioxidant is not restored by the following 
antioxidant in the chain, it begins to be a pro-oxidant. In this 
situation, the final effect of such supplementations would 
be no effect or a damaging effect.[60-63]
Other than beneficial effects of fruits and vegetables, there 
are some medicinal plants that are believed to ameliorate 
blood pressure. Some of these plants are presented in the 
following.
Medicinal plants effective in blood pressure 
Clinical trials of the plant extracts in human being have 
shown reliable evidence of antihypertensive effects. Even 
small diet changes such as cooking with garlic and savory 
herbs instead of salt can have beneficial effects in reduction 
of hypertension.[64] 
When considering medicinal plant therapy for hypertension, 
although medicinal products have advantages over 
synthetic drugs, however, lessons from prior disappointing 
attempts to reduce blood pressure and cardiovascular risks 
with antioxidants and these products should be considered. 
Some advantages of natural antioxidants and medicinal 
products are as follows:[65] 
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Good safety profile with limited side effects, good oral 
bioavailability, patient-friendly dosing regimen (once or 
twice daily dosing, concentrating in relevant tissues (brain, 
kidney, and/or vasculature), limited potential for pro-
oxidative activity and secondary cell signaling that may 
limit their effectiveness, mostly inhibition of ROS production 
rather than quenching ROS post-production, efficacious 
for hypertension originating from disparate etiologies, 
pleiotropic effects that go beyond blood pressure lowering 
and translate into reversal or prevention in progression of 
end organ damage, and finally limited interactions with the 
metabolism of concomitant antihypertensive therapies.[65]
It seems that antioxidant activity is not the sole cause of 
these plants in hypertension reduction. Because most of 
medicinal plants have antioxidant activity but it does not 
seem to be a correlation between antioxidant activity and 
their capacity in reduction of hypertension. 
Daily consumption of green tea or hibiscus, a delicious 
red tea, has been shown in studies to reduce high blood 
pressure. Herbal diuretics such as Buchu and Cornsilk 
tea can also help by eliminating water. Angelica contains 
compounds that act much like calcium channel blockers, 
which are often prescribed for high blood pressure and 
heart health. 
Some medicinal plants with antihypertension activity are 
discussed in the following.
Garlic or Allium sativum 
Garlic is from Alliaceae family or Liliaceae. Garlic has been 
shown to have antioxidant activity[66] and antihypertension 
effects. It has long been used for a variety of diseases 
including hypertension and hyperlipidemia. It increases 
nitric oxide production that results in smooth muscle 
relaxation and vasodilatation. Meta-analysis of data has 
demonstrated that garlic decreases BP in patients with 
increased systolic pressure.[11]
Annona muricata or Prickly custard apple
Annona muricata is a member of the family of Annonaceae 
and a species of the genus Annona, known mostly for its 
edible fruits Annona. The leaf extract of the plant has 
been reported to lower an elevated BP by decreasing the 
peripheral vascular resistance.[70] 
Apium graveolens or Celery
Celery is from Apiaceae family, effective against 
hypertension. It acts on liver and one type of hypertension 
is associated with liver. In a study in which the juice was 
mixed with equal amount of honey and about 8 ounces 
were taken orally three times each day for up to 1 week 
was useful in reducing HTN in 14 of 16 patients.[69] It has 
also been reported to reduce systolic and diastolic BP. The 
difference of BP in human beings before and after treatment 
has been found to be significant. It is also administered in 
HTN associated with pregnancy and climacteric.[70] 
Avena sativa or Green Oat
Avena sativa is from Poaceae/Gramineae family. It contains 
soluble fibers that can control hypertension. It improves 
blood lipid and glucose, too.[71] The addition of oat cereals 
to the normal diet of patients with HTN has been found to 
significantly reduce both systolic and diastolic BP.[72]
Blond psyllium or Indian plantago
Indian plantago is from Plantaginaceae family. It has been 
shown that daily consumption of 15 g Indian plantago can 
lower both systolic and diastolic blood pressure.[73]
Cassia absus or Chaksu
Cassia absus is from Caesalpiniaceae family. This plant is 
found in the tropical region of India. It has been shown that 
1-30 mg/kg of crude extract of C. absus dose dependently 
decreases the BP. Repeated injections of the same dose of the 
crude extract have been seen to produce tachyphylaxis.[74]
Cassia occidentalis or Coffee weed
Coffee weed is from Caesalpiniaceae family. In-vitro studies 
of the leaf extract of coffee weed have been shown to have 
a relaxant effect on the aortic rings. It is used in local folk 
medicine as an antihypertensive agent. The studies revealed 
that cassia extract may be relaxing smooth muscle and 
reducing BP by inhibiting Ca2+ influx through receptor-
operated channel and voltage-sensitive channel, showing 
its nonselectivity on these Ca2+ channels.[75]
Camellia sinensis or Tea
Camellia sinensis is from Theaceae family. Population 
research links consumption of green tea and oolong tea 
with a decreased risk of developing HTN. Research on 
black tea shows no effect on BP in people with HTN. It has 
also good effects in a wide range of other complications. 
Black bean is also from Fabaceae family. Crude extract of 
C. australe (1-100 mg/kg) has been shown to reduce both 
systolic and diastolic blood pressure in a dose-dependent 
manner. This fall in BP has been attributed to the saponin 
fraction and medicagenic acid glucoside present in the 
crude extract.[76,77]
Commelina virginica or Virginia dayflower
Virginia dayflower is from Commelinaceae family; it is 
native to the mideastern and southeastern United States. 
Whole plant extract has been reported to decrease the 
tension of phenylephrine-stimulated isolated guinea pig 
aorta rings by 15% to 35%; however, its antihypertension 
has not been investigated, yet.[78]
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Daucus carota or Carrot
Carrot is from Umbelliferae family. It has been used 
in traditional medicine to treat HTN. Isolation of two 
coumarin glycosides coded as DC-2 and DC-3. Intravenous 
administration of these compounds indicate that DC-2 and 
DC-3 may be acting through blockade of calcium channels, 
and this effect may be responsible for the BP-lowering effect 
of the compounds observed in the in vivo studies.[79]
Glycine max or Soybean
Soybean is from Fabaceae family. Soybean has been found 
to be effective as a hypotensive agent.[80]
Gossypium barbadense or Pima cotton
Pima cotton is from Malvaceae family. It has been shown 
that the leaf extract of Pima cotton decreases the tension of 
phenylephrine-stimulated isolated guinea pig aorta rings by 
15% to 35%. In Suriname’s traditional medicine, the leaves 
of the plant are used to treat HTN and delayed/irregular 
menstruation.[68,78]
Hibiscus sabdariffa or Roselle
Roselle is from Malvaceae family. The leaves of Roselle 
have been used traditionally as antihypertensive agent. Its 
antihypertensive has been reported in a couple of studies.[78,79] 
The antihypertensive effects of the crude extract of the HS 
have been attributed to mediation through acetylcholine 
and histamine like dependent mechanism through direct 
vasorelaxant effects.[79] The chronic administration of 
aqueous extract of HS has been reported to reverse cardiac 
hypertrophy in renovascular hypertensive rats.[80]
Clinical trials of the plant extract in human being have 
shown reliable evidence of antihypertensive effects.[81] 
Lavandula stoechas or French Lavender
French Lavender is from Lamiaceae family. Crude extract 
of L. stoechas has been reported to produce a fall in BP 
and HR in anesthetized rats. Pretreatment of atropine 
abolished the cardiovascular responses, suggesting that 
the antihypertensive and bradycardia effects of the crude 
extract may be mediated through mechanism(s) similar to 
that of acetylcholine.[82]
Linum usitatissimum or Linseed, Flaxseed
Linseed, Flaxseed is from Linaceae family. Flaxseed oil is rich 
in α-linolenic acid, an essential fatty acid that that is belonged 
to a group of substances called omega-3 fatty acids. Several 
studies suggest that diets rich in omega-3 fatty acids lower 
BP significantly in people with HTN. Daily consumption 
of 15 to 50 g/day of ground flaxseed can modestly reduce 
total cholesterol and low-density lipoprotein concentrations 
without altering triglycerides or high-density lipoprotein 
cholesterol. However, the exact mechanism is unclear.[82] 
Lycopersicon esculentum or Tomato
Tomato is from Solanaceae family. Its extract contains 
carotenoids, such as lycopene, beta carotene, and vitamin 
E, which are known as effective antioxidants, to inactivate 
free radicals and to slow the progress of atherosclerosis. The 
tomato extract of tomato has been shown to reduce BP in 
patients with mild HTN.[83] Tomato extract when added to 
patients treated with low doses of ACE inhibition, calcium 
channel blockers, or their combination with low-dose 
diuretics had a clinically significant effect-reduction of BP 
by more than 10 mmHg systolic and more than 5 mmHg 
diastolic pressure.[84] 
Ocimum basilicum or Basil
Basil is from Lamiaceae family. Crude extract of Basil has 
been shown to reduce systolic, diastolic, and mean BP in 
a dose-dependent manner with median effective dose of 
30 mg/kg. The cardiovascular effect of the extract has been 
attributed to eugenol, which exerts its effect by blocking 
the calcium channels.[85] 
Peganum harmala or Harmal
Harmal is from Nitrariaceae family. The crude extract 
fraction and all pure compounds: Harmine, harmaline, 
tetrahydroharmine, harmol, and harmaloi from Harmal 
produced antihypertensive effects in anesthetized rats in a 
dose-dependent manner.[86,87]
Punica granatum or Pomegranate
Pomegranate is from Lythraceae family. Researches have 
shown pomegranate juice reduces the activity of angiotensin 
converting enzymes (ACE) by about 36%. One study shows 
modest reduction in systolic BP after drinking 50 ml/day 
of pomegranate juice for a year. Another study shows no 
benefit after drinking 240 ml/day of the juice for 3 months.[88] 
Rauwolfia serpentina or Rauwolfia
Rauwolfia is from Apocynaceae family. Extracts of its 
different parts considered to be the most powerful 
hypotensive plant medicine. Reserpine, the purified alkaloid 
of R. serpentina, was the first potent drug widely used in the 
long-term treatment of HTN. Only a small dose is required 
to achieve results and to avoid side effects. Nasal congestion 
is the most common side effect. In 1952, reserpine was 
introduced under the name Serpasil in the treatment of 
HTN, tachycardia, and thyrotoxicosis. The combination of 
reserpine, dihydroergocristine, and a diuretic is still on the 
market. However, I may cause depression.[89]
Sesamum indicum or Sesame
Sesame is from Pedaliaceae family. Alcoholic extract of 
seeds (1-30 mg/kg) in a dose-dependent manner decreased 
blood pressure. Atropine (2 mg/kg) was reported to abolish 
the cardiovascular responses, indicating the presence of 
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acetylcholine-like substance in the seeds. Sesamin and 
sesaminol are the major phenolic constituents of sesame 
oil. A study in hypertensive patients indicated that sesame 
oil consumption remarkably reduced oxidative stress 
and simultaneously increased glutathione peroxidase, 
superoxidase dismutase, and catalase activities. These results 
support the hypothesis that sesame oil consumption may help 
to enhance antioxidant defense system in human beings. The 
investigators suggested that sesamin is a useful prophylactic 
treatment in HTN and cardiovascular hypertrophy.[90,91]
Solanum sisymbriifolium or Wild Tomato
Wild Tomato is from Solanaceae family. The root of S. 
sisymbriifolium has been used as a traditional medicine 
possessing diuretic and antihypertensive properties. 
The intravenous administration of the extract (50 and 
100 mg/kg) produced a significant decrease in BP in 
anesthetized hypertensive (adrenal regeneration HTN + 
deoxycorticosterone acetate) rats. Oral administration of the 
extract (10, 50, 100, and 250 mg/kg) also produced a dose-
dependent hypotensive effect in conscious hypertensive 
animals. The results suggested that nuatigenosido may play 
an important role in the therapeutic effects of this herb.[92] 
Theobroma cacao or Cocoa Butter
Cocoa Butter is from Malvaceae family. Cocoa powder, 
enriched with flavonoid constituents, is used for preventing 
cardiovascular disease. Flavonoids, contained in chocolate, 
stimulate formation of nitric oxide, increase vasodilatation, 
and reduce endothelial dysfunction. A growing body of 
clinical research also shows that daily consumption of dark 
or milk chocolate (T. cacao), 46 to 105 g daily, providing 213 
to 500 mg of cocoa polyphenols, can lower systolic BP by 
about 5 mmHg and diastolic by about 3 mmHg.[93] 
Uncaria rhynchophylla or Cat’s Claw herb
Cat’s Claw herb is from Rubiaceae family. It has been used 
to lower BP and to relieve various neurological symptoms. 
The hypotensive activity has been attributed to an indole 
alkaloid called hirsutine[85] that reduces intracellular Ca2+ 
level through its effect on the Ca2+ store as well as through its 
effect on the voltage-dependent Ca2+ channel.[94] Alteration 
in HR, possibly involves sympathetic mechanism, too.[95]
Vitex doniana Black plum
Black plum is from Verbenaceae family. The extract was 
found to exert hypotensive effect. Both the systolic and 
diastolic BPs were significantly reduced within 45 min after 
oral administration of the extract. The BP began to return 
to normal after 2 h.[96] 
Zingiber officinale or Ginger
Ginger is from Zingiberaceae family. Ginger root dose-
dependently (0.3-3 mg/kg) induced a fall in the arterial BP 
of anesthetized rats. Human trials for hypotensive effect of 
ginger have been few and generally used a low dose with 
inconclusive results.[97,98] 
Cautions in the use of medicinal plants 
The renewed interest in the search for new drugs from 
natural sources, especially from plant sources, has gained 
global attention during the last two decades. This attention 
is primarily due to the rich biodiversity, which promises 
a high diversity of chemicals with the potential novel 
structures and promising effects.[99-103] However, of this 
rich biodiversity, only a small portion has been studied 
for its medicinal potential.[104,105] Thus, natural plants and 
herbs can be our source of drugs, with fewer side effects 
and better bioavailability for treatment of HTN in future. 
However, it should be noted that the use of medicinal plants 
is not guaranteed to be nontoxic. For example ginseng is 
contraindicated for those in whom high blood pressure is 
dangerous, because high blood pressure has been reported in 
some ginseng consumers. This is because conflicting reports 
are about the effect of this medicinal plant on hypertension. 
It is not known yet whether ginseng is a cure for high blood 
pressure, or worsens it. Maintaining electrolyte balance is 
also important; for instance licorice (Glycyrrhiza glabra) 
can decrease potassium levels, cause sodium and water 
retention, and increase blood pressure.[106,107]
CONCLUSIONS
There is a proposed hypothesis relating the pathogenesis of 
hypertension and cardiovascular diseases to oxidative stress 
of arterial wall. However, antioxidant therapy has not been 
shown to be consistently beneficial. It seems that fruits and 
vegetables due to having a large variety of antioxidants are 
more effective than supplementation therapy with a limited 
number of antioxidants. Nevertheless, large clinical trials are 
needed to document the role of oxidative stress in hypertension 
and the possible treatment of hypertension with antioxidants.
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